Pharmaceutical Industry Hi-Cure Biotech

Pharma Monopoly Rights & PCD
December 15, 2017

Indian pharmaceutical area represents around 2.4 for every penny of the worldwide pharmaceutical industry in esteem terms and 10 for every penny in volume terms and is relied upon to extend at a Compound Annual Growth Rate (CAGR) of 15.92 for each penny to US$ 55 billion by 2020 from US$ 20 billion in 2015.

By 2016, India is required to be the third-biggest worldwide bland Active Pharmaceutical Ingredient (API) vendor showcase.

HI CURE BIOTECH IS a fastest growing player in Pharma Industries PCD Franchise Business in India. We have approximately 200+ products, which is probably the good range of product by a company in the country. We supply a wide range of pharmaceutical dosage like Tablets, Capsules, Syrups & Dry syrups, Injectables, Ophthalmic & ENT formulations, Herbal products, Dental products, Ointment & Creams etc in domestic and export market.

We have tie-ups with rumored GMP Certified/WHO consistent merchants, who help us take into account quality item necessities of our customers. Notwithstanding that we have the experience and information of Product Package planning and printing, which settles on Hicure Biotech a favored decision for Third-Party fabricating/Contract manufacturing for our customers.

Leave a Reply

Your email address will not be published. Required fields are marked *